December 19, 2025

From Cough to Clarity: Expanding the Respiratory Testing Toolkit

Is it time to expand the menu of testing options for respiratory infections?

The Pathologist

December 19, 2025

Europe’s Hidden HIV Burden

Surveillance suggests thousands may remain undiagnosed as late-stage presentations persist

The Pathologist

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 10, 2025

Optimizing Diagnostic Stewardship: The Lab Director’s Perspective

Programs that refine test ordering, performance, and reporting can reduce unnecessary treatments and enhance lab efficiency.

The Pathologist

December 09, 2025

DSCSA in Action: Real-World Lessons from US Supply Chain Implementation 

After a decade of preparation, the US pharmaceutical supply chain has seamless, serialized traceability for every prescription drug. Here are my lessons learned during that process.

The Medicine Maker

December 05, 2025

Spectroscopy Uncovers Shared Oxidative Marker in Stored Fish Species

Autofluorescence analysis reveals a consistent FAD-linked signal across salmon, seabream, and amberjack during chilled storage

The Analytical Scientist

December 01, 2025

Reaching Everyone, Everywhere: Breaking Barriers in Hepatitis C Testing

As global funding declines, decentralized testing, telehealth, and community-based care are helping expand access to HCV diagnosis and treatment

The Pathologist

November 30, 2025

Mount Sinai Rolls Out Innovative Program for Comprehensive Care for Older Adults With HIV

The success of Mount Sinai’s Comprehensive Care for Older Adults With HIV Program, which uses a collaborative team approach, including a community health worker, is leading to the rollout of the program to other institutions nationwide.

Mount Sinai New York

November 12, 2025

This Week’s Biopharma News: Clinical Hold for Heart Disease Gene Therapy

Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly

The Medicine Maker